Thursday, November 8, 2018

UPDATE 1-AstraZeneca sees years of growth as drug sales turn corner

* Q3 total revenue $3.34 bln vs consensus $3.30 bln (Adds CEO comment, shares, further context)
https://ift.tt/2DtniKH support@endlesssupplies.biz (Endless Supplies .Biz) November 08, 2018 at 04:02AM
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)